162 related articles for article (PubMed ID: 25950823)
21. [Cystic tubulopapillary adenoma with apocrine differentiation and BRAF V600E mutation. A case report and review of the literature].
Moreno Ontalba A; Gómez Durán Á; Ruiz Cabezas L; Cidoncha Pérez E; Díaz Delgado M; Rubio Fernández A
Rev Esp Patol; 2022 Sep; 55 Suppl 1():S64-S68. PubMed ID: 36075666
[TBL] [Abstract][Full Text] [Related]
22. An unusual complex cutaneous adnexal tumor composed of syringocystadenoma papilliferum, apocrine hidrocystoma, and clear cell syringoma.
Lin WL; Lin WC; Kuo TT; Chen CH; Hong HS
Dermatol Surg; 2007 Jul; 33(7):876-9. PubMed ID: 17598859
[No Abstract] [Full Text] [Related]
23. Dermoscopic aspects of syringocystadenoma papilliferum associated with nevus sebaceus.
Bruno CB; Cordeiro FN; Soares Fdo E; Takano GH; Mendes LS
An Bras Dermatol; 2011; 86(6):1213-6. PubMed ID: 22281917
[TBL] [Abstract][Full Text] [Related]
24. Syringocystadenoma papilliferum associated with verrucous carcinoma of the skin in the same lesion: Report of four cases.
Alegría-Landa V; Jo-Velasco M; Santonja C; Eraña I; Vergara-Sanchez A; Kutzner H; Requena L
J Cutan Pathol; 2020 Jan; 47(1):12-16. PubMed ID: 31449665
[TBL] [Abstract][Full Text] [Related]
25. Syringocystadenoma papilliferum of the eyelid.
Barbarino S; McCormick SA; Lauer SA; Milman T
Ophthalmic Plast Reconstr Surg; 2009; 25(3):185-8. PubMed ID: 19454927
[TBL] [Abstract][Full Text] [Related]
26. Syringocystadenoma papilliferum developing over hyperkeratosis of the nipple in a pregnant woman.
Ghazeeri G; Abbas O
J Am Acad Dermatol; 2014 Apr; 70(4):e84-e85. PubMed ID: 24629369
[No Abstract] [Full Text] [Related]
27. [Labia majora syringocystadenoma: a rare genital skin disease].
Zakia D; Zahra MF
Pan Afr Med J; 2014; 18():285. PubMed ID: 25469179
[No Abstract] [Full Text] [Related]
28. Familial eruptive syringoma.
Yaldiz M; Cosansu C; Erdem MT; Dikicier BS; Kahyaoglu Z
Hong Kong Med J; 2018 Apr; 24(2):200-202. PubMed ID: 29658486
[No Abstract] [Full Text] [Related]
29. Contiguous verrucous proliferations in syringocystadenoma papilliferum: A retrospective analysis with additional evaluation via mutation-specific BRAFV600E immunohistochemistry.
Friedman BJ; Sahu J; Solomides CC; Connolly DM; Lee JB
J Cutan Pathol; 2018 Mar; 45(3):212-216. PubMed ID: 29206289
[TBL] [Abstract][Full Text] [Related]
30. Familial syringomas: an example of gonadal mosaicism.
Smith KJ; Skelton HG
Cutis; 2001 Oct; 68(4):293-5. PubMed ID: 11710451
[No Abstract] [Full Text] [Related]
31. Clinicopathologic Study of Sialadenoma Papilliferum of the Minor Salivary Glands: A Series of 8 New Cases With BRAF V600E Mutation-specific Immunohistochemical Analysis.
Owosho AA; Shasteen AM; Aguirre SE; Summersgill KF
Int J Surg Pathol; 2023 Oct; 31(7):1265-1272. PubMed ID: 36632022
[No Abstract] [Full Text] [Related]
32. Activating mutations in the RAS/mitogen-activated protein kinase signaling pathway in sporadic trichoblastoma and syringocystadenoma papilliferum.
Shen AS; Peterhof E; Kind P; Rütten A; Zelger B; Landthaler M; Berneburg M; Hafner C; Groesser L
Hum Pathol; 2015 Feb; 46(2):272-6. PubMed ID: 25532942
[TBL] [Abstract][Full Text] [Related]
33. Histopathological evaluation of minor salivary gland papillary-cystic tumours: focus on genetic alterations in sialadenoma papilliferum and intraductal papillary mucinous neoplasm.
Nakaguro M; Urano M; Ogawa I; Hirai H; Yamamoto Y; Yamaguchi H; Tanigawa M; Matsubayashi J; Hirano H; Shibahara J; Tada Y; Tsuzuki T; Okada Y; Sato Y; Ikeda K; Sukeda A; Honda Y; Mikami Y; Nagao T
Histopathology; 2020 Feb; 76(3):411-422. PubMed ID: 31505033
[TBL] [Abstract][Full Text] [Related]
34. A case of syringocystadenocarcinoma papilliferum in situ occurring partially in syringocystadenoma papilliferum.
Arai Y; Kusakabe H; Kiyokane K
J Dermatol; 2003 Feb; 30(2):146-50. PubMed ID: 12692383
[TBL] [Abstract][Full Text] [Related]
35. Fine needle aspiration cytology of chondroid syringoma and syringocystadenoma papilliferum. A report of two cases.
Srinivasan R; Rajwanshi A; Padmanabhan V; Dey P
Acta Cytol; 1993; 37(4):535-8. PubMed ID: 8392255
[TBL] [Abstract][Full Text] [Related]
36. Syringocystadenoma papilliferum: report of first case on the pinna.
Bakshi J; Parida PK
J Laryngol Otol; 2006 Dec; 120(12):e45. PubMed ID: 17105677
[TBL] [Abstract][Full Text] [Related]
37. Syringocysadenoma papilliferum of the vulva: a rarity in gynaecology.
Steshenko O; Chandrasekaran N; Lawton F
BMJ Case Rep; 2014 May; 2014():. PubMed ID: 24872485
[TBL] [Abstract][Full Text] [Related]
38. Syringocystadenoma Papilliferum of the Anogenital Area and Buttocks: A Report of 16 Cases, Including Human Papillomavirus Analysis and HRAS and BRAF V600 Mutation Studies.
Konstantinova AM; Kyrpychova L; Nemcova J; Sedivcova M; Bisceglia M; Kutzner H; Zamecnik M; Sehnalkova E; Pavlovsky M; Zateckova K; Shvernik S; Spurkova Z; Michal M; Kerl K; Kazakov DV
Am J Dermatopathol; 2019 Apr; 41(4):281-285. PubMed ID: 30398985
[TBL] [Abstract][Full Text] [Related]
39. Hereditary syringomas: a case report.
Draznin M
Dermatol Online J; 2004 Oct; 10(2):19. PubMed ID: 15530309
[TBL] [Abstract][Full Text] [Related]
40. Cytomorphological features of syringocystadenoma papilliferum mimicking pilomatricoma at a rare location and in an unusual age group: A cytological diagnostic challenge.
Malik S; Singh P; Singh M; Ranga S
Diagn Cytopathol; 2024 Jan; 52(1):E1-E6. PubMed ID: 37782314
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
